ESC 365 - Professor John William Mcevoy

Speaker illustration

Professor John William Mcevoy

National University of Ireland, Galway (Ireland)

J. William ("Bill") McEvoy is Professor of Preventive Cardiology at NUI Galway and a Consultant Cardiologist at University Hospital Galway, IRL. He also serves as Medical and Research Director of the National Institute for Prevention and Cardiovascular Health (NIPC). Prof. McEvoy is a 2004 first class honours graduate of UCC School of Medicine, Cork, IRL. In 2008, he joined the Osler Medical Housestaff at the Johns Hopkins Hospital and University School of Medicine in Baltimore, Maryland, USA. He subsequently completed cardiology fellowship at Hopkins including advanced training in cardiac prevention, cardiac imaging, and cardiovascular epidemiology. He holds Masters degrees in cardiovascular epidemiology from the Johns Hopkins School of Public Health and in the education of health professionals from the Johns Hopkins School of Education. Prof. McEvoy’s research focuses on testing novel biomarkers of risk and clinical epidemiology; with an emphasis on hypertension and atherosclerosis.

Presentations Articles

Viviane Conraads Award Lecture

Event: ESC Preventive Cardiology 2024

Topic: European Association of Preventive Cardiology (EAPC)

Session: Viviane Conraads Award

INTERASPIRE: An international survey of secondary prevention of CVD

Event: ESC Congress 2023

Topic: Secondary Prevention

Session: Registries on cardiovascular risk and prevention

Con – we have to use widely available measurements

Event: ESC Preventive Cardiology 2023

Topic: Cardiovascular Risk Assessment

Session: Cardiovascular risk assessment: are we missing something?

The SCORE-2 and SCORE-2 OP models for primary prevention in adults

Event: ESC Preventive Cardiology 2022

Topic: European Association of Preventive Cardiology (EAPC)

Session: New models for cardiovascular risk assessment

Diastolic blood pressure limbo - how low can you go?

Event: EuroHeartCare - ACNAP Congress 2021

Topic: Hypertension

Session: New frontiers in hypertension

The Platelet Aggregation with tiCagrelor Inhibition and FentanYl Randomized Trial

Event: ESC Congress 2017

Topic: Thrombosis and coagulation

Session: Late-Breaking Science Posters PCI

ESC 365 is supported by